Enabling better
healthcare decisions.
In the provider workflow.
In patients’ everyday lives.
Enabling better
healthcare decisions.
In the provider workflow.
In patients’ everyday lives.
We’re reimagining care delivery
We partner with global life sciences companies, health plans, and providers to develop extraordinary solutions on our modular, AI-powered SaMD platform and in the EHR.
~10M Patients
Supported
70M+ Clinical
decisions evaluated
decisions evaluated
4 Continents with
regulatory clearance
~10M Patients
Supported
70M+ Clinical
decisions evaluated
decisions evaluated
4 Continents with
regulatory clearance
Medical-Grade AI™
Our clinically tested, conversational AI is built to supercharge existing and new digital applications, comply with rigorous life sciences regulatory standards, and take patient engagement to new heights.
Digital Products
We work with the world’s leading life sciences companies to develop DTx and companion products that drive positive outcomes and change lives.
EHR Solutions
Integrated seamlessly into the EHR, our point-of-care solutions enable patient identification, clinical trial recruitment, care guidelines, financial assistance, and more—all within the provider workflow.
The proof is in our partnerships
Together with our partners, we’re transforming healthcare. See what some of them have to say about us.
Rohit Bansal,
Otsuka Digital Health
“Amalgam has been a trusted partner in bringing Elevmi to life. Their AI-driven approach to caregiver engagement, combined with a balanced and collaborative mindset, helped us deliver a solution that truly resonates with families navigating Alzheimer’s.”
“Amalgam has been a trusted partner in bringing Elevmi to life. Their AI-driven approach to caregiver engagement, combined with a balanced and collaborative mindset, helped us deliver a solution that truly resonates with families navigating Alzheimer’s.”
Rohit Bansal,
Otsuka Digital Health
Rich Yang,
CEO, Biolinq
“As our software platform partner, Amalgam’s speed of execution contributed to a successful FDA De Novo grant for Biolinq Shine™, the first, fully autonomous wearable that integrates glucose, activity and sleep information in a single device. We’re incredibly grateful for Amalgam’s shared mission and talented team.”
“As our software platform partner, Amalgam’s speed of execution contributed to a successful FDA De Novo grant for Biolinq Shine™, the first, fully autonomous wearable that integrates glucose, activity and sleep information in a single device. We’re incredibly grateful for Amalgam’s shared mission and talented team.”
Rich Yang,
CEO, Biolinq
Regulatory-compliant security, privacy, and quality—wherever you need it.
At Amalgam, we make regulated software and algorithms simple. Our robust QMS and deep experience with the FDA and other notified bodies enables us to serve as the Manufacturer of Record for SaMD across the globe. We’re already cleared and scaling globally to deliver regulated software to patients and providers on four continents.
Let’s work together to launch in every market you want to reach.